A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f Prefilled Pen in Women Undergoing Ovulation Induction

Trial Profile

A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f Prefilled Pen in Women Undergoing Ovulation Induction

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2016

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Acronyms LoGo
  • Sponsors Merck KGaA; Merck Serono
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2016 Status changed from completed to discontinued because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays
    • 20 Nov 2014 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top